Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092404
Status:
COMPLETED
Last Update Posted:
2017-03-15
First Post:
2004-09-22
Brief Title:
Safety Tolerability and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin rHA in Children 12 to 18 Months of Age V205C-009COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Varicella |
| Measles |
| Mumps |
| Rubella |
Keywords: